Jacobs is in a recovery uptrend that has stalled in recent weeks, with the stock at $143.40 after a 1-year decline of 4.16% but a 3-month gain of 18.54%. The current price sits at approximately 60% of the 52-week range (low of $105.68, high of $168.44), meaning it is neither near its highs nor its lows — a neutral-to-constructive positioning that suggests the stock has repaired much of its earlier damage but has not yet reclaimed momentum leadership. The 6-month change of +11.65% and YTD gain of +5.95% confirm the intermediate trend has turned higher even as the trailing 12-month picture remains negative.

Short-term momentum has decelerated sharply: the 1-month change is -2.69%, a stark reversal from the +18.54% 3-month gain, and the stock is underperforming the S&P 500 by 1.73 percentage points over the past month (relative strength of -1.73). This divergence — a strong 3-month trend against a negative 1-month print — signals a temporary pullback or consolidation within an uptrend rather than a confirmed reversal, especially since the 1-year relative strength of -19.17 reflects the stock's earlier underperformance rather than current weakness. Volume of roughly 2.14 million shares and a short ratio of 3.75 days suggest no acute short-squeeze dynamic, but the recent drift lower from the August high of $151.98 to $143.40 warrants caution.

Key technical levels are well defined: support rests at the 52-week low of $105.68, with intermediate support near the September low of $140.53, while resistance sits at the 52-week high of $168.44 and nearer-term at the August peak of $151.98. A breakout above $152 would signal renewed momentum and likely target the $168 area, whereas a breakdown below $140 would put the 3-month uptrend at risk and expose the stock to a retest of the $120s. With a beta of 0.679, Jacobs is roughly 32% less volatile than the broader market, which argues for larger position sizing tolerance but also means the stock may lag in strong risk-on rallies — an important consideration given the max drawdown of -34.77% over the past year.

Revenue is growing robustly but unevenly: Q2 FY2026 revenue of $3.695 billion rose 26.95% year-over-year, a sharp acceleration from the $2.910 billion reported in Q2 FY2025 and above the $3.294 billion in Q1 FY2026. The Infrastructure & Advanced Facilities segment is the dominant driver at $3.336 billion, while PA Consulting contributes $358.6 million, meaning the core engineering business carries the growth burden. However, the multi-quarter trend is volatile — revenue dipped to $3.154 billion in Q4 FY2025 before rebounding — and the 26.95% YoY growth rate is flattered by comparison against a weak prior-year base, so investors should scrutinize whether this pace is sustainable or a one-quarter anomaly.

Profitability is the key concern: Q2 FY2026 produced a net loss of $45.9 million (EPS of -$0.34) and negative EBITDA of $33.3 million, a dramatic swing from Q1 FY2026 net income of $133.2 million and EBITDA of $300.1 million. Gross margin compressed to 21.51% in Q2 from 23.24% in Q1 and 24.31% in Q4 FY2025, while the trailing net margin is just 2.41% and the operating margin 7.18% — thin for an engineering services firm but not atypical given the pass-through nature of construction revenue. The Q2 loss appears driven by a $130.6 million pre-tax loss and a $49.4 million negative other-income line, suggesting non-operating or one-time charges rather than core operating deterioration, since operating income was -$81.2 million but gross profit remained positive at $794.9 million.

The balance sheet is leveraged but manageable: debt-to-equity stands at 0.744, the current ratio is 1.30, and ROE is 7.97% with ROA of 4.55%. Free cash flow is the weak spot — TTM FCF is $484.1 million, but Q2 FY2026 free cash flow was -$504.9 million due to a $501.1 million working-capital drain and $1.596 billion of debt repayment, though the company still held $1.488 billion in cash at quarter-end. The dividend payout ratio of 52.7% and yield of 0.86% are covered by full-year cash generation, but the negative quarterly FCF and reliance on working-capital swings mean the company's internal funding capacity is uneven, and the $219.8 million of stock repurchases in Q2 further pressure liquidity.